Form 8-K - Current report:
SEC Accession No. 0001193125-16-523746
Filing Date
2016-03-30
Accepted
2016-03-30 16:11:00
Documents
3
Period of Report
2016-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d135577d8k.htm 8-K 12490
2 EX-99.1 d135577dex991.htm EX-99.1 55178
3 GRAPHIC g135577g0326065438306.jpg GRAPHIC 3631
  Complete submission text file 0001193125-16-523746.txt   73974
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 161539734
SIC: 2834 Pharmaceutical Preparations